CRISPR THERAPEUTICS AG Stockholders' Equity Attributable to Noncontrolling Interest
CRISPR THERAPEUTICS AG (CRSP) had Stockholders' Equity Attributable to Noncontrolling Interest of -$51.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-22.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2017-03-10
- 2016-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$51.00K.
- 2015-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$27.00K.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2016-09-30 | -$51.00K 10-Q · filed 2016-11-22 |
| 2015-12-31 | -$27.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |